Who makes B: M207 3.8 mg, 30 min, thigh?

B: M207 3.8 mg, 30 min, thigh is developed by Zosano Pharma Corporation.

What development phase is B: M207 3.8 mg, 30 min, thigh in?

B: M207 3.8 mg, 30 min, thigh is in Phase 1.

Last reviewed 2026-04-19 · How we verify

Zosano Pharma Corporation · Phase 1 active Small molecule

Generic name	B: M207 3.8 mg, 30 min, thigh
Also known as	B: Zolmitriptan patch 3.8 mg, 30 min, thigh
Sponsor	Zosano Pharma Corporation
Modality	Small molecule
Phase	Phase 1

No approved indications tracked.

No common side effects on file.